Exercise Performance Clinical Trial
Official title:
Physiological Outcomes of High-intensity Interval Training With Post-exercise Blood Flow
Verified date | April 2024 |
Source | Nanyang Technological University |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
This research study revolves around the physiological outcomes of using post-exercise blood flow restriction (BFR) with high intensity short interval training (ST) The main aims of this study are to compare (i) aerobic performance outcomes, and (ii) anaerobic and muscular performance outcomes - between 2 groups of participants after either undergoing 3 weeks of ST + post-exercise BFR (BFR-ST) or traditional ST.
Status | Active, not recruiting |
Enrollment | 40 |
Est. completion date | September 30, 2024 |
Est. primary completion date | September 30, 2024 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | Male |
Age group | 18 Years to 40 Years |
Eligibility | Inclusion Criteria: - Male - 18-40 years - Actively performing endurance exercise (running or cycling) for at least 2 sessions (1 - 1.5h) per week - Healthy (free from illnesses) and no musculoskeletal injuries for the past 6 months - No history of cardiometabolic, vascular diseases or similar conditions (e.g., high blood pressure, peripheral vascular diseases, heart diseases, metabolic syndrome, diabetes, stroke, etc.). - Pass the pre-participation health screening tests - Physical Activity Readiness Questionnaire for Everyone (PAR-Q+) and Australian Institute of Sport Blood Flow Restriction (AIS BFR) pre-screening questionnaire (no history of any risk factors). - Achieve a maximum oxygen uptake (VO2max) of =40ml/kg/min during a maximal aerobic power cycling screening test. - Non-smoker - Drink alcohol less than 3 times each week and less than 3 drinks each time Exclusion Criteria: - Persons with any form of illnesses and/or musculoskeletal injuries for the past 6 months - Any history of cardiometabolic, vascular diseases or similar conditions which may worsen with the use of blood flow restriction during exercise - Fail the pre-participation health screening tests - Below 40ml/kg/min VO2max during maximal aerobic power cycling test - Smoker - Consumption of alcohol beyond that stated in the inclusion criteria. - History of asthma or taking medication for asthma. |
Country | Name | City | State |
---|---|---|---|
Singapore | Human Bioenergetics Laboratory, National Institute of Education, Nanyang Technological University | Singapore |
Lead Sponsor | Collaborator |
---|---|
Nanyang Technological University |
Singapore,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Maximum oxygen uptake and power | Will be assessed at baseline (Day 0 - Pre) and the change in this outcome 24 hours after 9 sessions of training over 3 weeks (Post) | ||
Primary | 20 km Cycling time trial | Will be assessed at baseline (Day 0 - Pre) and the change in this outcome 24 hours after 9 sessions of training over 3 weeks (Post) | ||
Primary | Wingate test of anaerobic power | Peak and mean power and rate of fatigue | Will be assessed at baseline (Day 0 - Pre) and the change in this outcome 24 hours after 9 sessions of training over 3 weeks (Post) | |
Secondary | Exercise economy | Oxygen uptake at a fixed load of 50% of maximum aerobic power | Will be assessed at baseline (Day 0 - Pre) and the change in this outcome 24 hours after 9 sessions of training over 3 weeks (Post) | |
Secondary | Isometric mid-thigh pull | Maximal strength assessment of lower body | Will be assessed at baseline (Day 0 - Pre) and the change in this outcome 24 hours after 9 sessions of training over 3 weeks (Post) | |
Secondary | Countermovement jump height | Vertical jump height assessment | Will be assessed at baseline (Day 0 - Pre) and the change in this outcome 24 hours after 9 sessions of training over 3 weeks (Post) |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03616093 -
The Impact of Acute (2 h) and Short-term (4 Days) Nitrate Supplementation in the Form of Red Beet Root Juice on Intense Intermittent Exercise Performance.
|
N/A | |
Completed |
NCT03294642 -
Potato Ingestion and Time-trial Performance
|
N/A | |
Completed |
NCT05831527 -
An Exploratory Investigation of a Supplement to Promote Gut Health
|
N/A | |
Not yet recruiting |
NCT03954665 -
Ketone Supplementation and Exercise Performance
|
N/A | |
Completed |
NCT04263246 -
Medium-Term Supplementation With Herbal Extract for Exercise Performance and Antioxidant Status
|
N/A | |
Not yet recruiting |
NCT05428228 -
Clinical Study to Evaluate the Effects of Two Novel Hydration Beverage Formulas on Rehydration in Healthy Adults
|
N/A | |
Recruiting |
NCT04004676 -
Ketone Supplementation, Glycogen Replenishment and Time Trial Performance Following Glycogen Lowering Exercise
|
N/A | |
Completed |
NCT03565523 -
The Effect of Dietary Nitrate Supplementation on Linear Running Sprint Performance, Agility and Vertical Jump Performance in a Rested and Fatigued State
|
N/A | |
Recruiting |
NCT06067100 -
U-LABA/ICS Effects on Exercise Performance, Indacaterol
|
N/A | |
Recruiting |
NCT06077019 -
Role of Lung Function for Exercise Capacity in Well-trained Individuals
|
N/A | |
Recruiting |
NCT06066606 -
U-LABA/ICS Effects on Exercise Performance, Vilanterol
|
N/A | |
Completed |
NCT05559372 -
Energy Drink Effects on Performance, Mood, and Cardiovascular Outcomes
|
N/A | |
Completed |
NCT03525561 -
Acetazolamide and Exercise Performance at Altitude
|
Early Phase 1 | |
Completed |
NCT03929575 -
Effects of Herbal Supplements on Endurance Exercise Performance
|
N/A | |
Completed |
NCT03977246 -
Effect of Open-placebo Intervention on Cycling Performance
|
N/A | |
Completed |
NCT03686982 -
The Impact of Supplementation With Novel Prototype Nutrition Bar on Nitric Oxide Bioavailability and Measures of Athlete Performance
|
N/A | |
Completed |
NCT06165523 -
Kefir Versus Milk on Time-Trial Performance in Masters Athletes
|
N/A | |
Completed |
NCT06390670 -
The Effect of Colostrum Bovinum Supplementation in Endurance Athletes
|
Phase 2/Phase 3 | |
Completed |
NCT05586295 -
Vitamin B Complex Improved Exercise Performance and Anti-fatigue
|
N/A | |
Recruiting |
NCT06374641 -
The Effects of a Novel Mitochondrial Substrate Supplement on Exercise Performance and Cognitive Function
|
N/A |